As of January 2023, the X-waiver is no longer required to prescribe buprenorphine for opioid use disorder. Any references to the X-waiver no longer apply. The educational content on this site that offers CME meets the MATE Act requirements of 8 hours of training required for DEA certification.
The Opioid and Stimulant Implementation Support-Training and Technical Assistance program (OASIS-TTA) at UCLA Integrated Substance Abuse Programs (ISAP) is a state-funded program supported by the Substance Abuse and Mental Health Services Administration (SAMHSA) State Opioid Response SOR3 Grant to the California Department of Health Care Services (DHCS). It consists of three major Training and Technical assistance projects:
Training content promotes best practices in specialty and primary care settings to enhance the delivery of medications for addiction treatment (MAT) and promote MAT sustainability. Under the expanded OASIS-TTA program, content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including but not limited to youth, American Indian/Alaska Native populations, and persons experiencing homelessness).
The OASIS-TTA program incorporates multiple targeted implementation support activities: